GENERAL COMMENTS
The prognosis of occupational asthma allowing continued exposure is an important issue. It is difficult to study and in my opinion any randomised trial of continued exposure or exposure cessation is unethical as most of those removed from exposure loose their livelihood. We are therefore left with observational studies which can always be criticised, as those able to continue exposure are unlikely to be representative of all those with occupational asthma. The current paper is one of the better ones attempting to answer these questions, and in particular the role of the eosoinophilic category of occupational asthma (not nearly as prevalent as in childhood-onset asthma) The current study is of 39 workers with positive specific occupational challenge tests from one of Europe's major centres for occupational asthma; they therefore have excellent evidence of occupational asthma. Patients studied were recruited over 19 years, they are therefore very unlikely to be all those studied at the centre. We have no information on how representative they are of all those with diagnosed occupational asthma to flour, woods, latex, tobacco dusts, persulphates and isocyanates. This should be added. The authors use a linear model of FEV1 decline which makes no attempt to control for the changes of exposure which are likely to be a major determinant of FEV1 decline. Separate regression lines, or one allowing for an inflection, should be used to separate periods of reduced exposure from periods of original exposure. 
GENERAL COMMENTS GENERAL COMMENTS
The authors report the result of an observational follow-up study of 39 subjects with occupational asthma (OA) caused by various agents. They found that a highest rate of decline in FEV1 was associated with a high (>3%) sputum eosinophil count at the initial evaluation and with the persistence of exposure (vs. reduced exposure) to the sensitizing agent. This is indeed the first report of the prognostic value of sputum eosinophilia in subjects with persistent/intermittent exposure, at least pertaining to the changes in FEV1. This finding, if further confirmed by other studies, may be relevant to the clinical management of OA.
SPECIFIC COMMENTS
Page 5, Patients and methods: The authors should state how the subjects included in this study were selected. Did the 39 participants represent ALL subjects that were diagnosed with OA in the study centre? The Discussion section suggests that some subjects suffering OA were able to be completely removed from exposure. How many subjects were lost for followed-up, and did they differ from those who were included in this cohort?
Page 6: A detailed description of the methodology used for performing specific inhalation challenges is not required for the purpose of this study.
Page 6, Sputum induction and processing: Hypertonic saline solution was nebulized …, and "was" (rather than "were") inhaled. Discussion: The first sentence "The present study confirms that the prognosis of occupational asthma is poor." is not correct. The authors should add "the prognosis of occupational asthma is poor in subjects who remain exposed to the sensitizing agent" since they did not assess subjects who avoided exposure. In addition this is not the most relevant result of the study. The first paragraph should be rewritten to focus on the main finding: The highest rate of decline in FEV1 was associated with a high (>3%) sputum eosinophil count at the initial evaluation and with the persistence of exposure to the causal agent.
REVIEWER
Catherine Lemiere Hôpital du Sacré-Coeur de Montréal,Université de Montréal REVIEW RETURNED 14-Jun-2014
GENERAL COMMENTS
There is no mention of ethics committee in the paper.
This is an interesting study that looked at prognosis factors of occupational asthma in workers who remained exposed to their offending factor at their workplace even if the level of exposure was decreased. The authors found that sputum eosinophilia and persistent work exposure were associated with a greater decline in FEV1.
Comments: As expected a persistent exposure was associated with a greater decline in FEV1. Although both persistence of exposure and sputum eosinophilia are associated with a greater decline in the logistic regression, it is very possible that there is an interaction between these two variables. Indeed, subjects who remained exposed are likely to have a greater level of airway inflammation. It would be important to know whether sputum eosinophilia is an independent prognosis factor or a consequence of the persistent exposure. This issue could be analyzed and discussed. As stated by the authors the limited sample size certainly reduces the power of the statistical analysis. Their logistic regression includes many variables (at least 7) for only 39 subjects. I wonder whether the authors had an adequate power for performing their regression analysis. I did not find any mention of acceptance of this project by an ethics committee. This should be mentioned along with the mention that the subjects signed an informed consent and accepted to participate in this study.
VERSION 1 -AUTHOR RESPONSE
Referee # 1 (Dr. Burge) -In effect we have considered in this study only the subjects who had an acceptable follow-up and a baseline sputum measurement, they represent something less than 50% of all subjects in whom a diagnosis of occupational asthma had been performed in the period considered. A comparison between these subjects and the other remaining ones (still at work at the time of the diagnosis but not included in the follow-up for several reasons) is reported in Table 1 of Appendix. There was no significant difference between the two groups as regards the main clinical and functional findings, as reported in a new sentence (page 5, line 125) -We were able to compute the FEV1 decline in the different period of exposure persistent or reduced) only in 9 subjects, in the other ones, the number of FEV1 measurements was too low in one of the two periods; in effect, the FEV1 decline was much lower during the period of reduced exposure in comparison with the period of persistent exposure, confirming the positive effect of the reduction of the work exposure (see our previous paper on this topic). We added a sentence with these data (page 9, line 247). This may explain also the difference between our data (which include both periods of persistent and reduced exposure) and the data reported in other papers including only periods of persistent exposure -As regards the multivariate analysis, we limited this analysis only for the independent variables which had demonstrated a significant (or a trend) correlation with the FEV1 decline in an univariate analysis. In this way, only three variables were included, and the results confirmed the role of baseline sputum eosinophilia in determining the decline of FEV1. We changed the sentence and the Table 4 (page 11, line 269) - Figures 1 and 2 still remain as previously, we do not adjusted the FEV1 decline for some potential influencing factors, because this has been considered in the multivariate analysis.
Referee # 2 (Dr. Vandenplas) -We included the details of the other subjects still at work at diagnosis and not included in the study (see comment to the previous referee) -We modified the methods section as suggested (page 6, line 156) -We did the change suggested (page 6, line 173) -We mantained the Table 2 as the original version, because the information about the different outcomes of patients who continued and those who reduced occupational exosure was already reported in a previous paper (Talini et al, Int Arch Allergy & Immunology 2012) . We added only in the text a short comment on the differennces in the outcomes of patients who had persistent or reduced occupational exposure during the follow-up (page 9, line 241) -We modified the Table 4 (see comment to the previous referee) including OR and confidence interval) -We re-write the first paragraph of the discussion, as correctly suggested (page 12, line 289)
Referee # 3 (Dr. Lemiere) -As regards the first observation, it is possible that persistent occupational exposure may cause greater airway inflammation, but we think that this observation is not pertinent to our data for the following reasons: a) sputum eosinophilia was assessed only at the baseline in subjects still exposed at the time of the diagnosis; b) the persistence or the reduction of the exposure has been evaluated during the follow-up, and no further sputum analysis was considered during the follow-up. We make this more clear also in the summary -As regards the multivariate analysis, in effect we limited the number of the independent variable thus reducing the risk of using too many variables (see comments to the previous referees) -We did not mention the authorization of the Ethic Committee, because the measurements we did in this sample of subjects were part of the common clinical routine in the evaluation of the outcome of asthma; only sputum induction and methacholine challenge test required a specific informed consent which were filled by all partecipants. Patients were informed on the use of their data for scientific evaluation (this was reported in a specific form filled by the subjects at the time of diagnosis) VERSION 2 -REVIEW REVIEWER Catherine Lemiere Hôptal du Sacré-Coeur de Montréal, Canada REVIEW RETURNED 22-Jul-2014 -The reviewer completed the checklist but made no further comments.
